These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A second mechanism employed by artemisinins to suppress Plasmodium falciparum hinges on inhibition of hematin crystallization. Ma W; Balta VA; West R; Newlin KN; Miljanić OŠ; Sullivan DJ; Vekilov PG; Rimer JD J Biol Chem; 2021; 296():100123. PubMed ID: 33239360 [TBL] [Abstract][Full Text] [Related]
5. Quinoline antimalarials decrease the rate of beta-hematin formation. Egan TJ; Ncokazi KK J Inorg Biochem; 2005 Jul; 99(7):1532-9. PubMed ID: 15927260 [TBL] [Abstract][Full Text] [Related]
6. Spectrally Resolved and Highly Parallelized Raman Difference Spectroscopy for the Analysis of Drug-Target Interactions between the Antimalarial Drug Chloroquine and Hematin. Wolf S; Domes R; Domes C; Frosch T Anal Chem; 2024 Feb; 96(8):3345-3353. PubMed ID: 38301154 [TBL] [Abstract][Full Text] [Related]
7. Quinoline drug-heme interactions and implications for antimalarial cytostatic versus cytocidal activities. Gorka AP; de Dios A; Roepe PD J Med Chem; 2013 Jul; 56(13):5231-46. PubMed ID: 23586757 [TBL] [Abstract][Full Text] [Related]
8. Use of the NP-40 detergent-mediated assay in discovery of inhibitors of beta-hematin crystallization. Sandlin RD; Carter MD; Lee PJ; Auschwitz JM; Leed SE; Johnson JD; Wright DW Antimicrob Agents Chemother; 2011 Jul; 55(7):3363-9. PubMed ID: 21518844 [TBL] [Abstract][Full Text] [Related]
9. Mode of action of quinoline antimalarial drugs in red blood cells infected by Kapishnikov S; Staalsø T; Yang Y; Lee J; Pérez-Berná AJ; Pereiro E; Yang Y; Werner S; Guttmann P; Leiserowitz L; Als-Nielsen J Proc Natl Acad Sci U S A; 2019 Nov; 116(46):22946-22952. PubMed ID: 31659055 [TBL] [Abstract][Full Text] [Related]
10. Docking studies on the binding of quinoline derivatives and hematin to Plasmodium falciparum lactate dehydrogenase. Cortopassi WA; Oliveira AA; Guimarães AP; Rennó MN; Krettli AU; França TC J Biomol Struct Dyn; 2011 Aug; 29(1):207-18. PubMed ID: 21696234 [TBL] [Abstract][Full Text] [Related]
11. Interactions of quinoline antimalarials with hematin in solution. Egan TJ J Inorg Biochem; 2006 May; 100(5-6):916-26. PubMed ID: 16384600 [TBL] [Abstract][Full Text] [Related]
12. The Effects of Quinoline and Non-Quinoline Inhibitors on the Kinetics of Lipid-Mediated β-Hematin Crystallization. Fitzroy SM; Gildenhuys J; Olivier T; Tshililo NO; Kuter D; de Villiers KA Langmuir; 2017 Aug; 33(30):7529-7537. PubMed ID: 28689414 [TBL] [Abstract][Full Text] [Related]
13. A common mechanism for blockade of heme polymerization by antimalarial quinolines. Sullivan DJ; Matile H; Ridley RG; Goldberg DE J Biol Chem; 1998 Nov; 273(47):31103-7. PubMed ID: 9813011 [TBL] [Abstract][Full Text] [Related]
14. Targeting of hematin by the antimalarial pyronaridine. Auparakkitanon S; Chapoomram S; Kuaha K; Chirachariyavej T; Wilairat P Antimicrob Agents Chemother; 2006 Jun; 50(6):2197-200. PubMed ID: 16723583 [TBL] [Abstract][Full Text] [Related]